Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients
| Autor: | Lévesque, H., Viallard, J.F., Houivet, E., Bonnotte, B., Voisin, S., Le Cam-Duchez, V., Maillot, F., Lambert, M., Liozon, E., Hervier, B., Fain, O., Guillet, B., Schmidt, J., Luca, L.E., Ebbo, M., Ferreira-Maldent, N., Babuty, A., Sailler, L., Duffau, P., Barbay, V., Audia, S., Benichou, J., Graveleau, J., Benhamou, Y. |
|---|---|
| Zdroj: | In Thrombosis Research May 2024 237:79-87 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect